Treatment of Essential Hypertension does not Normalize Capillary Rarefaction

OBJECTIVES: To determine if capillary rarefaction persists when hypertension is treated with angiotensin converting enzyme inhibitor, thiazidic diuretic and/or beta-blocker, and to identify which microcirculatory alterations (structural and functional) persist after anti-hypertensive treatment. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: de Araújo Penna, Guilherme Loures, de Freitas Garbero, Rodrigo, Neves, Mario Fritsch, Oigman, Wille, Bottino, Daniel Alexandre, Bouskela, Eliete
Formato: Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664718/
https://www.ncbi.nlm.nih.gov/pubmed/18925320
http://dx.doi.org/10.1590/S1807-59322008000500008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664718/
https://www.ncbi.nlm.nih.gov/pubmed/18925320
http://dx.doi.org/10.1590/S1807-59322008000500008

Ejemplares similares